Small molecules targeting γ-secretase and their potential biological applications
Jiachen Wen1, Dan Liu1, Linxiang Zhao1
1Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China.
European Journal of Medicinal Chemistry
|February 17, 2022
Summary
Gamma-secretase, a protein complex, mediates intramembrane proteolysis and is implicated in Alzheimer's disease. Recent structural insights enable the development of novel inhibitors and modulators for various diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- The gamma-secretase complex is a key intramembrane protease involved in various cellular processes.
- Dysregulation of gamma-secretase activity is linked to diseases such as Alzheimer's disease, inflammation, and cancer.
- Understanding its structure and function is crucial for therapeutic development.
Purpose of the Study:
- To review recent advancements in gamma-secretase inhibitors and modulators.
- To explore the potential therapeutic applications of targeting gamma-secretase.
- To highlight the impact of structural biology on drug design.
Main Methods:
- Review of recent clinical and preclinical studies on gamma-secretase modulators.
- Analysis of cryo-electron microscopy (cryo-EM) data for structural insights.
- Literature search on the role of gamma-secretase in disease pathogenesis.
Main Results:
- Recent cryo-EM studies have elucidated the atomic structure of the gamma-secretase complex.
- Numerous inhibitors and modulators targeting gamma-secretase are in clinical or preclinical development.
- These agents show promise for treating Alzheimer's disease and other indications.
Conclusions:
- Structural insights into gamma-secretase have accelerated the design of targeted therapies.
- Gamma-secretase inhibitors and modulators represent a promising therapeutic strategy for multiple diseases.
- Further research is warranted to fully explore the clinical potential of these agents.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
17.1K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.1K
01:26Targets for Drug Action: Overview
7.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.8K